Ertürk Ozan, Sağlam Muhammet Sefa, Gümüş Fatih, Bolcal Cengiz, Durdu Mustafa Serkan
Department of Cardiovascular Surgery, Memorial Ankara Hospital, Ankara, Türkiye.
Turk Gogus Kalp Damar Cerrahisi Derg. 2024 Dec 31;32(4 Suppl 2):094-94. doi: 10.5606/tgkdc.dergisi.2024.msb-72. eCollection 2024 Nov.
This study aimed to present our initial clinical experience and show the feasibility and safety of the right anterior minithoracotomy (RAT) approach for ascending aorta surgery with or without aortic valve involvement.
This single-center study included 112 patients who underwent ascending aortic replacement with or without aortic valve intervention between September 2018 and March 2024. Patients with aortic dissection and a history of previous cardiac surgery were excluded. RAT was performed in 48 (42.9%) patients, and conventional median sternotomy was performed in 64 (57.1%) patients. The primary endpoints included operative variables, reoperation for bleeding, transfusion requirements, extubation time, length of intensive care unit (ICU) and hospital stays, and postoperative complications. The secondary endpoint was 30-day mortality. Ascending aorta and aortic valve morphology were evaluated preoperatively using computed tomography angiography and Doppler echocardiography. Surgical procedures for both groups included the Bentall procedure, valve sparing root replacement (the David procedure), supracoronary ascending aorta replacement, and supracoronary ascending aorta replacement+aortic valve replacement.
Total operation time was significantly lower in the conventional median sternotomy group (237.84±24.87 min 259.57±27.41 min, p=0.0001). The mean ventilation time (12.73±2.96 h 19.43±4.21 h) and the mean length of ICU stay (1.71±0.86 days 3.6±1.71 days) were both shorter in the RAT group (p<0.0001 for both). The rate of wound infection was significantly lower in the RAT group (p=0.036).
Right anterior minithoracotomy is a novel and promising approach for ascending aortic surgery with or without aortic valve involvement. This study suggests that this approach is both feasible and safe. Furthermore, it has the advantages of better wound healing, shorter ICU and hospital stays, less blood transfusion, and a quicker extubation period.
本研究旨在介绍我们的初步临床经验,并展示右前小切口开胸术(RAT)用于升主动脉手术(无论是否累及主动脉瓣)的可行性和安全性。
这项单中心研究纳入了2018年9月至2024年3月期间接受升主动脉置换术(无论是否进行主动脉瓣干预)的112例患者。排除主动脉夹层患者和既往有心脏手术史的患者。48例(42.9%)患者接受了RAT手术,64例(57.1%)患者接受了传统正中开胸手术。主要终点包括手术变量、因出血再次手术、输血需求、拔管时间、重症监护病房(ICU)住院时间和住院时间以及术后并发症。次要终点是30天死亡率。术前使用计算机断层扫描血管造影和多普勒超声心动图评估升主动脉和主动脉瓣形态。两组的手术方式包括Bentall手术、保留瓣膜的主动脉根部置换术(David手术)、冠状动脉上缘升主动脉置换术以及冠状动脉上缘升主动脉置换术+主动脉瓣置换术。
传统正中开胸手术组的总手术时间显著更短(237.84±24.87分钟对259.57±27.41分钟,p=0.0001)。RAT组的平均通气时间(12.73±2.96小时对19.43±4.21小时)和平均ICU住院时间(1.71±0.86天对3.6±1.71天)均更短(两者p<0.0001)。RAT组的伤口感染率显著更低(p=0.036)。
右前小切口开胸术是一种用于升主动脉手术(无论是否累及主动脉瓣)的新颖且有前景的方法。本研究表明该方法既可行又安全。此外,它具有伤口愈合更好、ICU和住院时间更短、输血更少以及拔管期更快的优点。